Skip to main content
SpringerLink
Log in

Clinical Evaluation and Management of Diabetic Retinopathy

  • Chapter
Diabetic Nephropathy

Part of the book series: Developments in Nephrology ((DINE,volume 9))

  • 106 Accesses

Abstract

Ophthalmoscopic evaluation with either the direct or indirect ophthalmoscope has been the principal method of assessing the diabetic retina. Slip-lamp examination with a contact lens has proven highly valuable for studying more minute defects in the retinal structures. Photography of the retina, both regular and stereoscopic, has proven useful for carefully documenting retinal changes over long intervals of time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Novotny H, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation 24: 82–86, 1961.

    PubMed  CAS  Google Scholar 

  2. Brown JK, Jones AT. Retinopathy and diabetic control. Br J Ophthalmol, 48: 148–153, 1964.

    Article  PubMed  CAS  Google Scholar 

  3. Colwell JA. Effect of diabetic control on retinopathy. Diabetes 15: 497–499, 1966.

    PubMed  CAS  Google Scholar 

  4. Hardin RC, Jackson RL, Johnston TL, Kelly HG. The development of diabetic retinopathy: effects of duration and control of diabetes. Diabetes 5: 397–405, 1956.

    PubMed  CAS  Google Scholar 

  5. Jackson RL, Hardin RC, Walker GL, Hendricks AB, Kelly HG. Degenerative changes in young diabetic patients in relationship to level of control. Pediatrics 5: 959–971, 1950.

    PubMed  CAS  Google Scholar 

  6. Keiding NR, Root HF, Marble A. Importance of control of diabetes in prevention of vascular complications. JAMA 150: 964–969, 1952.

    CAS  Google Scholar 

  7. Schlesinger FG, Franken S, van Lange LTP, Schwartz F. Incidence and progression of retinal and vascular lesions in long-term diabetes: a follow-up of a group of patients over 7 years. Acta Med. Scand 168: 483–488, 1960.

    Article  PubMed  CAS  Google Scholar 

  8. Spoont S, Dyer WW, Day R, Blazer H. Incidence of diabetic retinopathy relative to the degree of diabetic control. Am J Med Sci 221: 490–494, 1951.

    Article  PubMed  CAS  Google Scholar 

  9. Dolger H. Clinical evaluation of vascular damage in diabetes mellitus. JAMA 134: 1289–1291, 1947.

    CAS  Google Scholar 

  10. Larsson Y, Sterky G. Long-term prognosis in juvenile diabetes mellitus. Acta Paediatr 51 (Suppl 130): 1–76, 1962.

    Google Scholar 

  11. Oakley WG, Pyke DA, Tattersall RB, Watkins PJ. Long-term diabetes: a clinical study of 92 patients after 40 years. Q J Med 43: 145–156, 1974.

    PubMed  CAS  Google Scholar 

  12. Taylor E., Adnitt PI. Factors relating to the progression of diabetic retinopathy. Am Heart J 82: 425–427, 1971.

    Article  PubMed  CAS  Google Scholar 

  13. Knowles HC. Long-term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians 84: 95–101, 1971.

    PubMed  Google Scholar 

  14. Knowles HC, Guest GM, Lampe J, Kessler M, Skillman TG. The course of juvenile diabetes treated with unmeasured diet. Diabetes 14: 239–273, 1965.

    PubMed  Google Scholar 

  15. Balodimos MC, Aiello LM, Gleason RE, Marble A. Retinopathy in mild diabetes of long duration. Arch Ophthalmol 81: 660–666, 1969.

    PubMed  CAS  Google Scholar 

  16. White P. Childhood diabetes. Its course, and influence on the second and third generations. Diabetes 9: 345–355, 1960.

    PubMed  CAS  Google Scholar 

  17. Caird FI, Garrett CJ. Progression and regression of diabetic retinopathy. Proc R Soc Med 55: 477–479, 1962.

    PubMed  CAS  Google Scholar 

  18. Szabo AJ, Stewart AG, Joron GE. Factors associated with increased prevalence of diabetic retinopathy: a clinical survey. Can Med Assoc J 97: 286–292, 1967.

    PubMed  CAS  Google Scholar 

  19. Parving HH, Noer I, Deckert T, Evrin PE, Nielson SL, Lyngsoe J, Mogensen CE, Rorth M, Svendsen PA, Trap-Jensen J, Lassen NA. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 12:- 161–166, 1976.

    Google Scholar 

  20. Miki E, Fukuda M, Kuzuya T, Kosaka K, Nakao K. Relation of the course of retinopathy to control of diabetes, age, and therapeutic agents in diabetic Japanese patients. Diabetes 18: 773–780, 1969.

    PubMed  CAS  Google Scholar 

  21. Pirart J. Diabete et complications degeneratives presentation d’une etude prospective portant sur 4400 cas observes entre 1947–1973. Diabete Metab 3: 97–107, 1977.

    PubMed  CAS  Google Scholar 

  22. Job D, Eschwege E, Guyot-Argenton C, Aubry JP, Tchobroutsky G. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes 25: 463–469, 1976.

    Article  Google Scholar 

  23. Askikaga T, Borodic G, Sims EAH. Multiple daily insulin injections in the treatment of diabetic retinopathy. The Job study revisited. Diabetes 27: 592–596, 1978.

    Article  Google Scholar 

  24. Constam GR. Zur spatprognose des diabetes mellitus. Helv Med Acta 32: 287–306, 1965.

    Google Scholar 

  25. Caird FI. Control of diabetes and diabetic retinopathy. In Symposium on the Treatment of Diabetic Retinopathy, Goldberg, MF, Fine, SL (eds.). PHS Pub. No. 1890. Health, Education and Welfare, 1968, Washington, DC: U.S. Department of 1968, pp. 107–114.

    Google Scholar 

  26. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl. 2): 789–830, 1970.

    Google Scholar 

  27. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl. 2): 789–830, 1970.

    Google Scholar 

  28. University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 218: 1400–1410, 1971.

    Article  Google Scholar 

  29. University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 217: 77–784, 1971.

    Google Scholar 

  30. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patience with adult-onset diabetes. Diabetes 25: 1129–1153, 1976.

    Google Scholar 

  31. Cahill GF, Etzwiler DD, Freinkel N. Diabetes 25 (editorial), 1976.

    Google Scholar 

  32. Shabo AL, Maxwell DS. Insulin-induced immunogenic retinopathy resembling the retinitis proliferans of diabetes. Trans Am Acad Ophthalmol Otolaryngol 81: 497–508, 1976.

    CAS  Google Scholar 

  33. Engerman RL. Animal models of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 81: 710–715, 1976.

    Google Scholar 

  34. Engerman R, Bloodworth JMB, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760–769, 1977.

    Article  PubMed  CAS  Google Scholar 

  35. British Multicentre Randomized Controlled Trial. Prolif erative diabetic retinopathy: treatment with xenon-arch photocoagulation. Brit Med J 1: 739–741, 1977.

    Article  Google Scholar 

  36. The Diabetic Retinopathy Study Research Group. Preliminary report of the effects of photocoagulation therapy. Amer J Ophthalmol 81: 383–102, 1976.

    Google Scholar 

  37. L’Esperance FA Jr. Diabetic retinopathy. In: Symposium on Diabetes Mellitus. Medical Clinics of North America 62(4): 767–785, 1978.

    Google Scholar 

  38. Meyer-Schwickerath G. Light-Coagulation. St. Louis: C.V. Mosby Co., 1960.

    Google Scholar 

  39. L’Esperance FA Jr. An ophthalmic argon laser photocoagulation system: design, construction, and laboratory investigations. Trans Amer Ophthal Soc 66: 827–904, 1968.

    PubMed  Google Scholar 

  40. L’Esperance FA Jr. Clinical photocoagulation with the krypton laser. Arch Ophthal 87: 693–700, 1972.

    PubMed  Google Scholar 

  41. L’Esperance FA Jr. Clinical photocoagulation with the frequency-doubled neodymium yttrium-aluminum-garnet laser. Am J Ophthal 71: 631–638, 1971.

    PubMed  Google Scholar 

  42. L’Esperance FA Jr. Ophthalmic lasers: photocoagulation, photoradiation and surgery. St. Louis: C.V. Mosby Co., 1983.

    Google Scholar 

  43. L’Esperance FA Jr., James WA Jr. Diabetic retinopathy: clinical evaluation and management. St. Louis: C.V. Mosby Co., 1981.

    Google Scholar 

  44. James WA Jr., L’Esperance FA Jr. Treatment of diabetic optic nerve neovascularization by extensive retinal photocoagulation. Am J Ophthalmol 78: 939–947, 1974.

    PubMed  Google Scholar 

  45. L’Esperance FA Jr. Ocular photocoagulation. St. Louis: C.V. Mosby Co., 1975.

    Google Scholar 

  46. Little HP. In: Diabetic Retinopathy, Lynn JR, Snyder WB, Vaiser A (eds). New York: Grune and Stratton, 1974, pp. 133–144.

    Google Scholar 

  47. L’Esperance FA Jr. (ed). Current diagnosis and management of chorioretinal diseases. St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  48. L’Esperance FA Jr, Freidman EA, Mondschein LG. Long term retention of vision following panretinal photocoagulation in diabetics. In: Diabetic Renal-Retinal Syndrome 2 Prevention and Management, L’Esperance FA Jr., Friedman EA (eds). New York: Grune and Stratton, 1982, pp. 285–300.

    Google Scholar 

  49. Diabetic Retinopathy Study Research Group. Preliminary report of the effects of photocoagulation therapy. Am J Ophthalmol 81: 383–402, 1976.

    Google Scholar 

  50. Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. Arch Ophthalmol 97: 654–655, 1979.

    Google Scholar 

  51. Davis MD. Discussion of presentation by Dr. George W. Blankenship. Ophthalmology 86(1):- 76–78, 1979.

    Google Scholar 

  52. Mandelcorn MS, Blankenship G, Machemer R. Pars plana vitrectomy for the management of severe diabetic retinopathy. Am J Ophthalmol 81: 561–570, 1976.

    PubMed  CAS  Google Scholar 

  53. L’Esperance FA Jr. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A (ed). St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  54. Okun E. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A. (ed). St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  55. Douvas NG. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A. (ed). St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  56. Kloti R. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A. (ed). St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  57. Ryan SJ, Michels RG. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A (ed). St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  58. Shea M, Young PW. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A (ed). St. Louis: C.V. Mosby Co., 1977.

    Google Scholar 

  59. Machemer R. Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. Ophthalmology 88 (7): 643–646, 1981.

    PubMed  CAS  Google Scholar 

  60. Aaberg TM. Pars plana vitrectomy for diabetic traction retinal detachment. Ophthalmology 88 (7): 639–642, 1981.

    PubMed  CAS  Google Scholar 

  61. L’Esperance FA Jr, et al. Long term retention of vision following vitrectomy in diabetics. In: Diabetic Renal-Retinal Syndrome 2 Prevention and Management, Friedman EA, L’Esperance E A Jr. (eds). New York: Grune and Stratton, 1982, pp. 277–283.

    Google Scholar 

  62. Luft R, Olivecrona H, Ikkos D, Kornerup I, Ljundgren H. Hypophysectomy in man—further experiences in severe diabetes mellitus. Br Med J 2: 752–756, 1955.

    Article  PubMed  CAS  Google Scholar 

  63. Poulsen JE. Recovery from retinopathy in a case of diabetes with Simmonds’ Disease. Diabetes 2: 7–12, 1953.

    PubMed  CAS  Google Scholar 

  64. Bradley RF, Rees SB, Fager CA. Pituitary ablation in the treatment of diabetic retinopathy. Med Clin North Am 49: 1105–1124, 1965.

    PubMed  CAS  Google Scholar 

  65. Kohner EM. Diabetic retinopathy: cause, treatment and prognosis. Unpublished M.D. thesis, University of London, 1969.

    Google Scholar 

  66. Kohner EM. In: Diabetic Retinopathy, Lynn JR, Snyder WB, Vaiser A (eds). New York: Grune and Stratton, 1974, pp. 205–214.

    Google Scholar 

  67. Kohner E, Hamilton A, Joplin G, Fraser TR. Florid diabetic retinopathy and its response to treatment by photocoagulation. Diabetes 25: 104–110, 1976.

    Article  PubMed  CAS  Google Scholar 

  68. Marble A. Late complications of diabetes. A continuing challenge. Diabetologia 12: 193–199, 1976.

    Article  PubMed  CAS  Google Scholar 

  69. Kohner EM. A controlled trial of pituitary ablation. In: Diabetic Retinopathy, Lynn JR, Snyder WB, Vaiser A (eds). New York: Grune and Stratton, 1974, pp. 205–214.

    Google Scholar 

  70. Kohner E, Hamilton A, Joplin G, et al. Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes 25: 104–110, 1976.

    Article  PubMed  CAS  Google Scholar 

  71. Bloodworth JMB, Engerman RL. Diabetic microangiopathy in the experimentally diabetic dog and its prevention by careful control with insulin. Diabetes 22 (suppl. 1): 290, 1973.

    Google Scholar 

  72. Didier Jr, Eschwege E, Guyot-Argenton C, et al. Effect of multiple daily injections on the course of diabetic retinopathy. Diabetes 25: 463–469, 1976.

    Article  Google Scholar 

  73. Cahill CF Jr, Etzwiler DD, Freinkel N. Blood glucose control in diabetes. Diabetes 25: 237–239, 1976.

    Google Scholar 

Download references

Authors
  1. Francis A. L’esperance Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Renal Disease, State University of New York, Downstate Medical Center, Brooklyn, New York, 11203, USA

    Eli A. Friedman M.D. (Professor of Medicine, Chief) (Professor of Medicine, Chief)

  2. Sansum Medical Research Foundation, Santa Barbara, 93105, California, USA

    Charles M. Peterson M.D. (Director of Research) (Director of Research)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

L’esperance, F.A. (1986). Clinical Evaluation and Management of Diabetic Retinopathy. In: Friedman, E.A., Peterson, C.M. (eds) Diabetic Nephropathy. Developments in Nephrology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2287-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2287-0_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9410-8

  • Online ISBN: 978-1-4613-2287-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation